Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cognitively Stimulating Activities
36%
Leptin
33%
Neurodegeneration
33%
AMPA Receptor (AMPAR)
33%
Hexamer
33%
Receptor Internalization
33%
Abnormal Involuntary Movements
33%
L-DOPA
33%
Positive Allosteric Modulator
33%
Nicotinic Acetylcholine Receptor (nAChR)
27%
Nicotine
27%
PNU-120596
22%
Levodopa-induced Dyskinesia
16%
Methyllycaconitine
16%
Alzheimer's Disease
11%
PHA-543613
11%
Dyskinesia
11%
Receptor Subtypes
11%
Alzheime's Disease
11%
Neuroprotective Action
8%
Transcriptomic Signature
6%
Hypoglycemia Prevention
6%
GT1-7
6%
Hypoglycaemic Clamp
6%
Influenza Infection
6%
Insulin Function
6%
Hippocampal Synapses
6%
Bioactive
5%
Chronic Administration
5%
Signal Properties
5%
Drug Development
5%
6-hydroxydopamine (6-OHDA)
5%
Primates
5%
Additive Effect
5%
Nicotinic Ligands
5%
Biochemical Signaling
5%
Striatum
5%
Female Rats
5%
Extrastriatal
5%
Acetylcholine
5%
Rapid Desensitization
5%
Rodents
5%
Non-selective
5%
Antidyskinetic
5%
Pharmacology, Toxicology and Pharmaceutical Science
Side Effect
37%
Positive Allosteric Modulator
33%
Dyskinesia
33%
Transcriptome
33%
Antipsychotic
33%
Infection
33%
Levodopa
33%
Atypical Antipsychotics
33%
Adverse Event
22%
Nicotine
20%
Nicotinic Receptor
16%
Methyllycaconitine
12%
Levodopa-Induced Dyskinesia
12%
Cerebrovascular Accident
11%
Tumor Necrosis Factor
11%
Transforming Growth Factor Beta
11%
Brain Derived Neurotrophic Factor
11%
Drug Repositioning
11%
Selenoamino Acid
11%
Volinanserin
11%
Platelet Derived Growth Factor Beta Receptor
11%
Amisulpride
11%
Influenza
11%
Risperidone
11%
Venous Thromboembolism
11%
Thromboembolism
11%
Diseases
11%
Atherosclerosis
11%
Receptor Subtype
8%
Phytohaemagglutinin
8%
Neuroscience
Leptin
100%
Neuroprotective Agent
41%
Amyloid Protein
37%
Alzheimer's Disease
37%
AMPA Receptor
35%
Nerve Cell Degeneration
33%
Internalization
33%
Insulin
33%
Central Nervous System
13%
Synaptic Plasticity
11%
Synapse
8%
Peptide
7%
Neuronal Cell Death
7%
Leptin Receptor
6%
Blood Brain Barrier
6%
Neurodegenerative Process
6%
Glutamate Receptor
6%
Brain Function
6%
Insulin Receptor
6%
Hippocampus
6%
Hippocampal Formation
6%
Enhancer Region
6%
